Legato Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,554
| Closed | -$1.51M | – | 581 |
|
|
2024
Q4 | $1.51M | Buy |
29,554
+4,057
| +16% | +$207K | 0.2% | 173 |
|
|
2024
Q3 | $1.3M | Buy |
25,497
+6,482
| +34% | +$331K | 0.16% | 224 |
|
|
2024
Q2 | $852K | Buy |
19,015
+9,135
| +92% | +$409K | 0.11% | 297 |
|
|
2024
Q1 | $462K | Sell |
9,880
-1,695
| -15% | -$79.3K | 0.06% | 453 |
|
|
2023
Q4 | $412K | Buy |
+11,575
| New | +$412K | 0.05% | 449 |
|